We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Motif Bio Plc | LSE:MTFB | London | Ordinary Share | GB00BVVT4H71 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.55 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
28/3/2019 09:43 | dave4545 - 28 Mar 2019 - 09:03:24 - 13 of 18 MOTIF BIO PLC (MTFB) $5.00 price objective on the stock. - MTFB Moderating a post that explains the truth about that price target. That just proves what a all out conman you are cappick | depjoe | |
28/3/2019 09:32 | newtothisgame3 what a laugh | depjoe | |
28/3/2019 09:20 | newtothisgame3 LOL LOL | depjoe | |
28/3/2019 09:18 | what a con man he is FAR FAR WORSE than desperate dave trust NOTHING from this man MAKES UP LIES UPON LIES | depjoe | |
28/3/2019 09:13 | I will stake my considerable advfn reputation That the FDA will not remedy the MFTB situation They can't afford to take the risk you see As its life or death if wrong for you and me | buywell2 | |
28/3/2019 09:09 | even you wouldn’t do that would you dave takes some doing making you look like an angel LOL | depjoe | |
28/3/2019 09:03 | Moderating a post that explains the truth about that price target. That just proves what a all out conman you are cappick | dave4545 | |
28/3/2019 08:58 | you make hatey look like an angel far far worse LIES and LIES | depjoe | |
28/3/2019 05:00 | #Motif #Bio PLC 🔥👀 #MTFB : #LSE Inside Bar (#Bullish) 2019 Mar 27 DAILY Short-Term #Bullish | newtothisgame3 | |
27/3/2019 22:41 | dave are you working with him on this PUMP and DUMP | depjoe | |
27/3/2019 22:40 | You need help cappick. Seriously mentally ill ! Goodnight | dave4545 | |
27/3/2019 22:32 | desperate dave FAILURE Tops is RESPECTED dave 6151 followers dave just 512 LOL | depjoe | |
27/3/2019 22:27 | desperate dave second only to his mate two peas in pod both CON MEN | depjoe | |
27/3/2019 22:25 | $5 target lol when it's just 6p lol lol Desperate or what, probably a broker target from years ago | dave4545 | |
27/3/2019 21:14 | #MOTIF #BIO #MTFB UP 94% | newtothisgame3 | |
27/3/2019 20:22 | That scumbag dice trading24/7 is making up many false reports. newtothisgame3 | firestorm911 | |
27/3/2019 16:56 | Based on recent history at these levels good chance of a spike. Derisk when it does and leave some in over next 12 month incase approvel is granted for a garantueed multipe bagger. Thats my plan anyway. Only risk what you can afford. | philipc240 | |
27/3/2019 15:33 | The fact is, the BOD managed to get the placing away and raised £2.7 mill. Ask yourself how and why? The meeting with the FDA is to scope out a way to get this to market. You cant blame the FDA for showing a certain amount of diligence. The new and existing investors have imho been made aware of the massive upward potential hence them stumping up £2.7 mill. I am very comfortable with my investment here and so should you be, in the knowledge e.bigger players than us minnows have skin in the game. | eigde 007 | |
27/3/2019 10:44 | !FOLLOWFEED!YOUTUBEV MOTIF BIO PLC/S (MTFB) Receives Buy Rating from Northland Securities Posted by Bob Marten on Mar 27th, 2019 Northland Securities restated their buy rating on shares of MOTIF BIO PLC/S (NASDAQ:MTFB) in a research report sent to investors on Tuesday. They currently have a $5.00 price objective on the stock. “We anticipate the Co. to provide guidance on iclaprim’s path forward in June. Key Points Motif Completes $3.55MM Raise: Pre-open, Motif announced that it has completed placement of 45MM ordinary shares priced at 6 pence, raising gross proceeds of £2.7MM (~$3.55MM USD) providing the Company with additional working capital. The offering, if translated into ADS equivalents, would approximate 2.5MM ADS shares at $1.58 per share. Through FDA Update: The net proceeds from the offering, combined with existing cash resources, and adjusted for repayment of $0.5MM to Hercules Capital, approximate $5- $5.5MM. We anticipate cash balances to be sufficient to fund operations beyond its receipt of minutes anticipated in early-June from the May 3rd Type A meeting with the FDA.”,” the firm’s analyst wrote. #MTFB After factoring in the company’s cash position, potential cash from the exercise of outstanding warrants, and dividing by the fully diluted ADS share count of 18.6 million leads to a valuation of $28 per share. | newtothisgame3 | |
27/3/2019 08:56 | Bought a few. This looks interesting | volsung | |
27/3/2019 08:48 | For God's sake, depjoe/dave4545, there are other readers/posters on here besides you and your worst enemy. Give it a rest, please. | lionheart69uk1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions